Anzeige
Erschienen in:
01.12.2015 | Original Research Article
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A National Analysis of Data from 10-Year Post-marketing Surveillance
Erschienen in: Drug Safety | Ausgabe 12/2015
Einloggen, um Zugang zu erhaltenAbstract
Introduction
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, severe and potentially fatal cutaneous adverse drug reaction (the mortality rate is up to 10 %) associated with numerous and apparently heterogeneous drugs. The aetiology is unknown.
Objective
To report Italian cases of DRESS over a 10-year period.
Methods
We searched the National Pharmacovigilance Network (NPN) for the term ‘drug reaction with eosinophilia and systemic symptoms’ from 1 January 2004 to 1 January 2014, to identify all reports of DRESS. Each case was checked to avoid duplication.
Results
In the NPN, we identified 91 serious cases of DRESS: 68 were spontaneous, still-unpublished reports, while 23 additional cases were derived from screening of the scientific literature, performed by marketing authorization holders. Notably, the single common element linking all cases of DRESS was intake of a drug containing an aromatic ring.
Conclusion
Thanks to the largest national DRESS case series ever reported, we were able to hypothesize, for the first time, that there is an association between use of drugs containing an aromatic ring in their chemical structure and DRESS. This might aid understanding of the aetiology of DRESS and facilitate diagnosis.